Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank86
3Y CAGR+51.1%
5Y CAGR+34.3%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+51.1%/yr
vs -10.6%/yr prior
5Y CAGR
+34.3%/yr
Recent acceleration
Acceleration
+61.8pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
4.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $10.31M | -49.2% |
| 2024 | $20.27M | +55.4% |
| 2023 | $13.04M | +337.0% |
| 2022 | $2.98M | +561.9% |
| 2021 | $451000.00 | -80.9% |
| 2020 | $2.36M | -74.7% |
| 2019 | $9.32M | +99.1% |
| 2018 | $4.68M | +475.4% |
| 2017 | $813000.00 | +9.1% |
| 2016 | $745000.00 | - |